Clinical trials
Small Fiber Neuropathy trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 5 |
| Completed | 4 |
| Terminated | 3 |
| Recruiting | 2 |
| Suspended | 1 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Academisch Ziekenhuis Maastricht | 2 |
| Erasmus Medical Center | 1 |
| Foundation University Islamabad | 1 |
| Ilker Fatih Sari | 1 |
| Johns Hopkins University | 1 |
| Maastricht University Medical Center | 1 |
| Massachusetts General Hospital | 1 |
| National Taiwan University Hospital | 1 |
| Ospedale Regionale di Lugano | 1 |
| St. Luke's Hospital and Health Network, Pennsylvania | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Small Fiber Neuropathy | 17 |
| Neuralgia | 3 |
| Chronic Pain | 2 |
| Diabetes Mellitus | 2 |
| Fibromyalgia | 2 |
| Pain | 2 |
| Peripheral Nervous System Diseases | 2 |
| Agnosia | 1 |
| Breast Neoplasms | 1 |
| Chronic Cough | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.